BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• FDA

  China Food And Drug Administration Approves Gilead’s Sovaldi (Sofosbuvir) For Treatment Of Chronic Hepatitis C Virus Infection

  September 25, 2017

   · 

  7 min read
• Pharm Country

  Ocugen, Inc. Announces FDA Acceptance Of Investigational New Drug Application For OCU310 (Brimonidine/Steroid Combination Therapy) And Initiates Proof Of Concept Study For Treatment Of Dry Eye Disease

  September 25, 2017

   · 

  3 min read
• Policy

  Allergan Receives Refusal To File Letter From FDA For Vraylar (Cariprazine) Supplemental New Drug Application (Snda) For The Treatment Of Negative Symptoms In Schizophrenia

  September 25, 2017

   · 

  5 min read
• Biotech Beach

  Amgen Foundation Pledges Up To $5 Million To Hurricane Maria Relief Efforts

  September 25, 2017

   · 

  7 min read
• Pharm Country

  Systech International And Inno4Life Launch Faster, Fully-Integrated Pharmaceutical Serialisation Solution To Help Meet The European Falsified Medicines Directive (FMD)

  September 25, 2017

   · 

  2 min read
• Business

  Elekta And IBA Enter An MOU Regarding A Comprehensive Partnership Including Joint Software Development And Sales To Advance Proton Therapy Treatments

  September 25, 2017

   · 

  3 min read
• Business

  Lannett’s Board Of Directors Initiates CEO Search

  September 25, 2017

   · 

  4 min read
• Lone Star Bio

  Kaneka North America To Increase The Off List Selling Price For Kane Ace Specialty Additives

  September 25, 2017

   · 

  1 min read
• Business

  NantKwest Builds Financial And Commercial Expertise With The Appointment Of Fred Driscoll To Its Board Of Directors

  September 25, 2017

   · 

  4 min read
• FDA

  Bristol-Myers Squibb’s Opdivo (Nivolumab) Receives FDA Approval For The Treatment Of Hepatocellular Carcinoma Patients Previously Treated With Sorafenib

  September 25, 2017

   · 

  18 min read